Search

everythinglearnresearchcommunity

for

Search:↓

The current system can't fully test all combination treatments, so alternative methods and regulatory flexibility are needed.

Bendamustine combined with rituximab is an effective and well-tolerated treatment for certain types of lymphoma.

Finasteride improves hair growth and satisfaction in men with male pattern baldness but may cause sexual side effects.

Blocking the enzyme that turns testosterone into DHT can safely and effectively treat enlarged prostate.

Epirubicin is as effective as doxorubicin for cancer treatment with less heart damage, but doesn't work on doxorubicin-resistant cancers.

Male hormones, particularly DHT, are linked to male pattern hair loss, and treatments like finasteride can help, but they don't work for postmenopausal women's hair loss, which may have different causes.

PLD is an effective and safer alternative for treating breast cancer.

The consensus document recommends a comprehensive treatment plan for Hidradenitis Suppurativa, including various medications, surgery, lifestyle changes, and the need for more research and resources.

Capecitabine is as effective as intravenous treatments with fewer side effects, but requires careful management of Hand-foot syndrome and patient education.

Teriflunomide is an effective and safe first-line oral treatment for relapsing multiple sclerosis.

2007 research improved understanding of prostate cancer risk, diagnosis, and treatment, but also showed the need for personalized treatment and further study on certain therapies' risks.

Androgen therapy can help with symptoms like low libido in women, but more research is needed to understand its long-term safety and effects on health.

ATIR101 improves survival in stem cell transplant patients; Australian stem cell treatment decisions are influenced by regulation changes.

The document concludes that various dermatological treatments and drugs can cause skin reactions and side effects.

A new protein linked to Alzheimer's was discovered, and a hair loss treatment showed effectiveness but had some sexual side effects.

Developing microRNA-based treatments is hard but has potential.

Bimatoprost is promising for treating some types of hair loss but needs more testing for androgenetic alopecia.

Aldesleukin can treat certain cancers and increase HIV patient CD4+ counts but often causes severe side effects.

Dutasteride 0.5 mg daily improves hair growth safely in men with hair loss.

Oral paclitaxel plus encequidar improved tumor response and caused less neuropathy but more serious infections than intravenous paclitaxel.

The new chemotherapy combination for advanced lung cancer showed a 35.7% response rate but caused significant side effects.

The combination treatment showed a higher response rate but no significant survival benefits.

New partnerships, clinical trials, and drug approvals marked progress in therapeutic delivery in July 2018.

Bendamustine, often combined with other drugs, is effective and less toxic for certain blood cancers, but less effective for young, fit patients with CLL.

Boron neutron capture therapy for head and neck cancer can cause side effects like mouth sores and skin irritation, which vary depending on where the treatment is aimed.

New drugs and combination therapies are improving treatment for lower urinary tract symptoms.

In September 2016, there were major advancements and promising clinical trials in stem cell research and regenerative medicine.

Breast cancer patients taking CDK4/6 inhibitors are more likely to experience fatigue, hair loss, and mouth sores.

JAK inhibitors are effective in treating various immune-related diseases, not just rheumatoid arthritis.

Topical JAK inhibitors may help treat some skin conditions but need more research.